312 related articles for article (PubMed ID: 17300564)
1. Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead.
Berman EL; Donaldson CE; Giblin M; Martin FJ
Clin Exp Ophthalmol; 2007; 35(1):5-12. PubMed ID: 17300564
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
[TBL] [Abstract][Full Text] [Related]
3. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
4. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years.
Okimoto S; Nomura K
J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
[TBL] [Abstract][Full Text] [Related]
8. Globe conserving treatment of the only eye in bilateral retinoblastoma.
Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
[TBL] [Abstract][Full Text] [Related]
9. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
10. [Intraocular retinoblastoma: new therapeutic options].
Imhof SM; Moll AC; Schouten-van Meeteren AY
Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2165-70. PubMed ID: 11727614
[TBL] [Abstract][Full Text] [Related]
11. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile, management, and outcome of retinoblastoma in singapore.
Lim FP; Soh SY; Iyer JV; Tan AM; Swati H; Quah BL
J Pediatr Ophthalmol Strabismus; 2013; 50(2):106-12. PubMed ID: 23244241
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
[TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
15. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
16. [Retinoblastoma update].
Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F
Arch Pediatr; 2016 Jan; 23(1):112-6. PubMed ID: 26679524
[TBL] [Abstract][Full Text] [Related]
17. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of unilateral retinoblastoma.
Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
[TBL] [Abstract][Full Text] [Related]
19. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.
Camp DA; Dalvin LA; Schwendeman R; Lim LS; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):1997-2004. PubMed ID: 31755437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
